Found: 15
Select item for more details and to access through your institution.
The influence of drug-induced metabolic enzyme activity inhibition and CYP3A4 gene polymorphism on aumolertinib metabolism.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1392849
- By:
- Publication type:
- Article
Crizotinib inhibits the metabolism of tramadol by non-competitive suppressing the activities of CYP2D1 and CYP3A2.
- Published in:
- PeerJ, 2024, p. 1, doi. 10.7717/peerj.17446
- By:
- Publication type:
- Article
Cyy-287, a novel pyrimidine-2,4-diamine derivative, efficiently mitigates inflammatory responses, fibrosis, and lipid synthesis in obesity-induced cardiac and hepatic dysfunction.
- Published in:
- PeerJ, 2024, p. 1, doi. 10.7717/peerj.17009
- By:
- Publication type:
- Article
The effect of icotinib or apatinib on the pharmacokinetic profile of oxycodone in rats and the underlying mechanism.
- Published in:
- PeerJ, 2023, p. 1, doi. 10.7717/peerj.16601
- By:
- Publication type:
- Article
Functional evaluation of cyclosporine metabolism by CYP3A4 variants and potential drug interactions.
- Published in:
- Frontiers in Pharmacology, 2023, v. 13, p. 1, doi. 10.3389/fphar.2022.1044817
- By:
- Publication type:
- Article
cyy-287, a novel pyrimidine-2,4-diamine derivative, inhibits tumor growth of EGFR-driven non-small cell lung cancer via the ERK pathway.
- Published in:
- Acta Biochimica et Biophysica Sinica, 2022, v. 54, n. 10, p. 1540, doi. 10.3724/abbs.2022139
- By:
- Publication type:
- Article
CYP2D6 gene polymorphism and apatinib affect the metabolic profile of fluvoxamine.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.985159
- By:
- Publication type:
- Article
The Influence of CYP3A4 Genetic Polymorphism and Proton Pump Inhibitors on Osimertinib Metabolism.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.794931
- By:
- Publication type:
- Article
An Indole-2-Carboxamide Derivative, LG4, Alleviates Diabetic Kidney Disease Through Inhibiting MAPK-Mediated Inflammatory Responses.
- Published in:
- Journal of Inflammation Research, 2021, v. 14, p. 1633, doi. 10.2147/JIR.S308353
- By:
- Publication type:
- Article
Antifibrotic Effect of a Novel Selective 11β-HSD2 Inhibitor (WZ51) in a rat Model of Myocardial Fibrosis.
- Published in:
- Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2021.629818
- By:
- Publication type:
- Article
MD2 activation by direct AGE interaction drives inflammatory diabetic cardiomyopathy.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-15978-3
- By:
- Publication type:
- Article
Influences of Corydalis decumbens on the Activities of CYP450 Enzymes in Rats with a Cocktail Approach.
- Published in:
- BioMed Research International, 2019, p. 1, doi. 10.1155/2019/9614781
- By:
- Publication type:
- Article
Osthole Protects against Acute Lung Injury by Suppressing NF-κB-Dependent Inflammation.
- Published in:
- Mediators of Inflammation, 2018, p. 1, doi. 10.1155/2018/4934592
- By:
- Publication type:
- Article
Kaempferol attenuates hyperglycemia-induced cardiac injuries by inhibiting inflammatory responses and oxidative stress.
- Published in:
- Endocrine (1355008X), 2018, v. 60, n. 1, p. 83, doi. 10.1007/s12020-018-1525-4
- By:
- Publication type:
- Article
An Aza resveratrol–chalcone derivative 6b protects mice against diabetic cardiomyopathy by alleviating inflammation and oxidative stress.
- Published in:
- Journal of Cellular & Molecular Medicine, 2018, v. 22, n. 3, p. 1931, doi. 10.1111/jcmm.13477
- By:
- Publication type:
- Article